ArticleWellcome open research2023

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).

Kathryn Maitland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.